Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) EBT Margin: 2019-2025

Historic EBT Margin for Revolution Medicines (RVMD) over the last 5 years, with Sep 2025 value amounting to 2,670.69%.

  • Revolution Medicines' EBT Margin was N/A to 2,670.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 8,999.92%, marking a year-over-year change of. This contributed to the annual value of 23,767.64% for FY2024, which is 2756636.00% up from last year.
  • As of Q3 2025, Revolution Medicines' EBT Margin stood at 2,670.69%, which was up 138.41% from -6,953.44% recorded in Q4 2024.
  • Over the past 5 years, Revolution Medicines' EBT Margin peaked at 4,129.69% during Q1 2024, and registered a low of -21,724.26% during Q4 2023.
  • In the last 3 years, Revolution Medicines' EBT Margin had a median value of -1,770.72% in 2023 and averaged -4,236.46%.
  • Per our database at Business Quant, Revolution Medicines' EBT Margin tumbled by 2,135,485bps in 2023 and then soared by 1,477,082bps in 2024.
  • Revolution Medicines' EBT Margin (Quarterly) stood at -556.83% in 2021, then spiked by 18,742bps to -369.41% in 2022, then slumped by 2,135,485bps to -21,724.26% in 2023, then surged by 1,477,082bps to -6,953.44% in 2024, then reached 2,670.69% in 2025.
  • Its last three reported values are 2,670.69% in Q3 2025, -6,953.44% for Q4 2024, and 4,129.69% during Q1 2024.